PaulBrooksGaudinMD

PubMed

• 228 citations
  The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma.
  Geert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, Andrew J Evans, Glen Kristiansen
  The American Journal of Surgical Pathology. 2020-08-01
• 23 citations
  Intrarenal Schwannoma: A Report of Four Cases Including Three Cellular Variants
  Isabel Alvarado-Cabrero, Andrew L. Folpe, John R. Srigley, Paul B. Gaudin, Abraham T Philip
  Modern Pathology. 2000-08-01
• 372 citations
  Prostate-specific membrane antigen is produced in tumor-associated neovasculature.
  Sam S. Chang, Denise S. O'Keefe, Dean Bacich, Victor E. Reuter, Warren D. W. Heston
  Clinical Cancer Research. 1999-10-01

Journal Articles

• Prostate carcinoma with squamous differentiation: an analysis of 33 cases  
  Parwani AV, Kronz JD, Genega EM, Gaudin P, Chang S, Epstein JI, Am J Surg Pathol, 1/1/2004
• Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma  
  Chang SS, Reuter VE, Heston WD, Gaudin PB, Urology, 1/1/2001
• Metastatic renal cell carcinoma of neovasculature expresses prostate-specific membrane antigen  
  Chang SS, Reuter VE, Heston WD, Gaudin PB, Urology, 1/1/2001
• Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma  
  Genega EM, Hutchinson B, Reuter VE, Gaudin PB, Mod Pathol, 1/1/2000
• Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy  
  Gong MC, Chang SS, Watt F, O'Keefe DS, Bacich DJ, Uchida A, Bander NH, Reuter VE, Gaudin PB, Molloy PL, Sadelian M, Heston WD, Mol Urol, 1/1/2000
• Intrarenal schwannoma: a report of four cases including three cellular variants  
  Alvarado-Cabrero I, Folpe AL, Srigley JR, Gaudin P, Philip AT, Reuter VE, Amin MB, Mod Pathol, 1/1/2000
• Prostate-specific membrane antigen: present and future applications  
  Chang SS, Gaudin PB, Reuter VE, Heston WD, Urology, 1/1/2000
• Short Term neoadjuvant androgen deprivation therapy does not affect prostate-specific membrane antigen (PSMA) expression in prostate tissues  
  Chang SS, Reuter VE, Heston WDW, Hutchinson B, Grauer LS, Gaudin PB, Cancer, 1/1/2000
• Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection  
  Harrison LE, Gaudin PB, Brennan MF, Arch Surg, 1/1/1999
• Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer  
  Yang XJ, Lecksell K, Gaudin P, Epstein JI, Am J Surg Pathol, 1/1/1999
• Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prost...  
  Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, Grann A, Gaudin P, Fuks Z, Leibel SA, J Clin Oncol, 1/1/1999
• Five different anti-PSMA antibodies confirm prostate-specific membrane antigen (PSMA) expression in tumor-associated neovasculature  
  Chang SS, Reuter VE, Heston WDW, Bander NH, Grauer LS, Gaudin PB, Cancer Res, 1/1/1999
• Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues  
  Gaudin PB, Zelefsky MJ, Leibel SA, Fuks Z, Reuter VE, Am J Surg Pathol, 1/1/1999
• Prostate-specific membrane antigen is produced in tumor-associated neovasculature  
  Chang SS, O'Keefe DS, Bacich DJ, Reuter VE, Heston WDW, Gaudin PB, Clin Cancer Res, 1/1/1999
• Prostate-Specific Membrane Antigen: Much More Than a Prostate Cancer Marker  
  Chang SS, Gaudin PB, Reuter VE, O'Keefe DS, Bacich DJ, Heston WD, Mol Urol, 1/1/1999
• Sarcomas and related proliferative lesions of prostatic stroma Authors’ reply [Letter]  
  Gaudin P, Rosai J, Epstein JI, Am J Surg Pathol, 1/1/1999
• Pathologic handling and reporting of tissue specimens in patients treated with neoadjuvant hormonal therapy: report of the pathology committee  
  Grignon DJ, Bostwick DG, Civantos F, Garnick MB, Gaudin P, Srigley JR, Mol Urology, 1/1/1999
• Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer  
  Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NB, Venkatramen S, Reuter VE, Fair WR, Ling CC, Fuks Z, Int J Radiat Oncol Biol Phys, 1/1/1998
• Pathologic features from prostate needle biopsy predict prognosis after I-125 brachytherapy  
  Grann A, Gaudin PB, Raben A, Wallner K, Radiat Oncol Investig, 1/1/1998
• Distinct altered patterns of p27Kip1 expression in benign prostatic hyperplasia and prostatic carcinoma  
  Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI, J Natl Cancer Inst, 1/1/1998
• Histopathologic effects of radiation and hormonal therapies on benign and malignant prostate tissues  
  Gaudin PB, J Urol Pathol, 1/1/1998
• Sarcomas and related proliferative lesions of specialized prostatic stroma A clinicopathologic study of 22 cases  
  Gaudin PB, Rosai J, Epstein JI, Am J Surg Pathol, 1/1/1998
• Accuracy of grading gliomas on CT-guided stereotactic biopsies: a survival analysis  
  Gaudin PB, Sherman ME, Brat DJ, Zahurak M, Erozan YS, Diagn Cytopathol, 1/1/1997
• Renal Oncocytoma A clinicopathologic study of 70 cases  
  Perez-Ordonez B, Hamed G, Russo, Gaudin PB, Reuter VE, Am J Surg Pathol, 1/1/1997
• Incidence and clinical significance of high grade prostatic intraepithelial neoplasia in TURP specimens  
  Gaudin PB, Sesterhenn IA, Wojno KJ, Mostofi FK, Epstein JI, Urology, 1/1/1997
• Join now to see all